Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.

<h4>Background</h4>The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eliete Dalla Corte Frantz, Camila Crespo-Mascarenhas, Andre Rodrigues C Barreto-Vianna, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/155b6bcff49e435d88479510422226cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:155b6bcff49e435d88479510422226cd
record_format dspace
spelling oai:doaj.org-article:155b6bcff49e435d88479510422226cd2021-11-18T09:03:42ZRenin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.1932-620310.1371/journal.pone.0067192https://doaj.org/article/155b6bcff49e435d88479510422226cd2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23894285/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the regulation of the pancreas and glucose intolerance of mice fed high-fat (HF) diet.<h4>Methods</h4>C57BL/6 mice fed a HF diet (8 weeks) were treated with aliskiren (50 mg/kg/day), enalapril (30 mg/kg/day) or losartan (10 mg/kg/day) for 6 weeks, and the protective effects were extensively compared among groups by morphometry, stereological tools, immunostaining, Western blotting and hormonal analysis.<h4>Results</h4>All RAS inhibitors significantly attenuated the increased blood pressure in mice fed a HF diet. Treatment with enalapril, but not aliskiren or losartan, significantly attenuated body mass (BM) gain, glucose intolerance and insulin resistance, improved the alpha and beta cell mass and prevented the reduction of plasma adiponectin. Furthermore, enalapril treatment improved the protein expression of the pancreatic islet Pdx1, GLUT2, ACE2 and Mas receptors. Losartan treatment showed the greatest AT2R expression.<h4>Conclusion</h4>Our findings indicate that ACE inhibition with enalapril attenuated several of the deleterious effects of the HF diet. In summary, enalapril appears to be responsible for the normalization of islet morphology and function, of alpha and beta cell mass and of Pdx1 and GLUT2 expression. These protective effects of enalapril were attributed, primarily, to the reduction in body mass gain and food intake and the enhancement of the ACE2/Ang (1-7) /Mas receptor axis and adiponectin levels.Eliete Dalla Corte FrantzCamila Crespo-MascarenhasAndre Rodrigues C Barreto-ViannaMarcia Barbosa AguilaCarlos Alberto Mandarim-de-LacerdaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e67192 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Eliete Dalla Corte Frantz
Camila Crespo-Mascarenhas
Andre Rodrigues C Barreto-Vianna
Marcia Barbosa Aguila
Carlos Alberto Mandarim-de-Lacerda
Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
description <h4>Background</h4>The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the regulation of the pancreas and glucose intolerance of mice fed high-fat (HF) diet.<h4>Methods</h4>C57BL/6 mice fed a HF diet (8 weeks) were treated with aliskiren (50 mg/kg/day), enalapril (30 mg/kg/day) or losartan (10 mg/kg/day) for 6 weeks, and the protective effects were extensively compared among groups by morphometry, stereological tools, immunostaining, Western blotting and hormonal analysis.<h4>Results</h4>All RAS inhibitors significantly attenuated the increased blood pressure in mice fed a HF diet. Treatment with enalapril, but not aliskiren or losartan, significantly attenuated body mass (BM) gain, glucose intolerance and insulin resistance, improved the alpha and beta cell mass and prevented the reduction of plasma adiponectin. Furthermore, enalapril treatment improved the protein expression of the pancreatic islet Pdx1, GLUT2, ACE2 and Mas receptors. Losartan treatment showed the greatest AT2R expression.<h4>Conclusion</h4>Our findings indicate that ACE inhibition with enalapril attenuated several of the deleterious effects of the HF diet. In summary, enalapril appears to be responsible for the normalization of islet morphology and function, of alpha and beta cell mass and of Pdx1 and GLUT2 expression. These protective effects of enalapril were attributed, primarily, to the reduction in body mass gain and food intake and the enhancement of the ACE2/Ang (1-7) /Mas receptor axis and adiponectin levels.
format article
author Eliete Dalla Corte Frantz
Camila Crespo-Mascarenhas
Andre Rodrigues C Barreto-Vianna
Marcia Barbosa Aguila
Carlos Alberto Mandarim-de-Lacerda
author_facet Eliete Dalla Corte Frantz
Camila Crespo-Mascarenhas
Andre Rodrigues C Barreto-Vianna
Marcia Barbosa Aguila
Carlos Alberto Mandarim-de-Lacerda
author_sort Eliete Dalla Corte Frantz
title Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
title_short Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
title_full Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
title_fullStr Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
title_full_unstemmed Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
title_sort renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/155b6bcff49e435d88479510422226cd
work_keys_str_mv AT elietedallacortefrantz reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice
AT camilacrespomascarenhas reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice
AT andrerodriguescbarretovianna reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice
AT marciabarbosaaguila reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice
AT carlosalbertomandarimdelacerda reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice
_version_ 1718420949276033024